Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06JBA
|
||||
Former ID |
DIB001640
|
||||
Drug Name |
HGS-TR2J
|
||||
Synonyms |
KMTR2; Trail-R2 human antibody; TRAIL-R2 mAbs, HGS/Kirin; TRAIL-R2 monoclonal antibody (cancer), Human Genome Sciences/Kirin; TRAIL-R2 monoclonal antibody (cancer), Human Genome Sciences/Kyowa Hakko Kirin
|
||||
Drug Type |
Antibody
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Discontinued in Phase 1 | [548059] | ||
Company |
Kirin Brewery Co Ltd
|
||||
Target and Pathway | |||||
Target(s) | Tumor necrosis factor receptor superfamily member 10B | Target Info | [544097] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
TNFalpha Signaling Pathway | |||||
PANTHER Pathway | Apoptosis signaling pathway | ||||
p53 pathway | |||||
Pathway Interaction Database | TRAIL signaling pathway | ||||
Direct p53 effectors | |||||
Caspase Cascade in Apoptosis | |||||
WikiPathways | DNA Damage Response | ||||
Apoptosis-related network due to altered Notch3 in ovarian cancer | |||||
Apoptosis | |||||
miR-targeted genes in squamous cell - TarBase | |||||
miR-targeted genes in muscle cell - TarBase | |||||
miR-targeted genes in lymphocytes - TarBase | |||||
miR-targeted genes in epithelium - TarBase | |||||
Extrinsic Pathway for Apoptosis | |||||
Apoptosis Modulation and Signaling | |||||
miRNA Regulation of DNA Damage Response | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.